Editorial
Cardiopulmonary transplantation in children: a reason for optimism?
| The first 150 words of the full text of this article appear below. |
Heart transplants are now an established mode of treatment for heart failure in adults. Are they justified in children? We believe they are.
The aim is to provide a normal quality of life. However, for some, particularly those with an acute cardiomyopathy, it can be a question of life or death. Long term survival is limited by the development of coronary artery disease (probably as a result of chronic rejection) and post-transplant lymphoproliferative disease (PTLD). However, data from the International Society of Heart and Lung Transplantation (URL <www.ISHLT.org/regist>) shows a one year survival of 80%, five year survival of 70%, and a "half life" of 12.2 years.
So who should be considered? The ISHLT database shows roughly equal
numbers of children with congenital heart disease and some form of
cardiomyopathy, though this depends on the age group. In those under 1 year of age, over two thirds have congenital
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
